|
|
Welcome To: JOEY'S DESK
MRPIS-10007
Update June 2008
Methadone Retrospective Postmortem Investigational Study
The scheduled completion date for the MRPIS has been amended at the discretion of the program administrator and director. We are now able to accept additional autopsy reports with a deadline of October 31, 2008 for sending reports. The study has been extended for one year with the new completion date of March 2009. A preliminary report will be released on our website on approximately July/August 2008.
Thank you for your support as we all move forward together in this cause.
***************************************************
MAMA.Org's "Petition For Change" By: Joey To sign this petition: http://www.thepetitionsite.com/1/RxMethadoneDeaths/ Section I
●Introduction to the Dangers of Toxic Drugs, i.e., Methadone –The single most important factor of any drug is its margin of safety. Methadone is a Dangerous and Potentially Fatal Drug that is beginning to affect our country in epidemic proportions. Methadone’s clandestine toxic properties build up quickly and can rapidly become fatal, rendering the patient unable to help himself and unaware of the danger presented ●
Section II
●Establishing the Protection of patient rights by ‘Right to Know, Full Disclosure’ to protect the safety and welfare of patients unaware of potentially hazardous and toxic drugs. The Physician and Pharmacist should be mandated to disclose any and all available information on a prescribing drug and waivers should be signed stated that the hazards have been fully explained and accepted by the patient stating that full disclosure of a drugs safety has been provided and documented, both the physician and patient should sign; as well as the patient and pharmacist at the dispensing pharmacy. All drugs of potential lethality should especially be thoroughly explained to the patient and benefits outweigh the risk of death, this must be documented and signed by the patient and physician. Should the patient refuse and ask for a safer alternative medication, it should be mandated that their can be no repercussions from the physician for refusing the medication. ●
Section III
● Physicians, Nurse Practitioners, Medical Assistants, Nurses, Pharmacist, and Clinical Personnel should receive additional training and continuing education on medications that pose a special risk of lethality and toxicity, drugs that have potential for lethality and toxic plasma concentrations within a relatively short time or after only a small dose. This training should be documented and presented to a patient upon request and training should be on an ongoing basis.●
Section IV
●National Medical/Patient Adverse Drug Safety Database – Immediate Posting of Potential Lethal Drugs-Immediate share capability across the country. This service will be free of charge to the public ●
Section V
●Public Education and Awareness into communities, clinics, offices, schools, hospitals, and public libraries to increase the awareness and potentially toxic drugs and drug combinations. This should be through all media outlets available radio, newspaper, PSA’s, school programs, community programs, outreach, handouts, internet ads, mandatory drug company distribution, etc.●
Section VI
●DEA compliance issues and more easy accessibility to physician offices, clinics, hospitals, and greater enforcement powers in jurisdictions with higher incidence of diversion. Tougher criminal penalties for diversion should also be investigated●
Section VII
●Patients at risk with preexisting cardio-pulmonary conditions or patients predisposed to conditions such as Long QT Syndrome should be extensively tested and approved for use of cardio-pulmonary toxic drugs by specialist in their respective fields prior to prescribing drugs in this category ●
Section VIII
●Full Congressional Investigation and appointment of the Attorney General to investigate the patterns of Pharmaceutical Companies and their extent of prior knowledge of drug safety issues and failure to report these issues and safety concerns. Mandatory ruling that drug companies must sponsor ongoing research and studies for drug safety with an independent source of investigation. Drug companies should face criminal penalties if they don’t comply or failure to report preexisting knowledge of a dangerous drug●
Section IX
●FDA giving more control and proactive role in it’s responsibilities to overall margins of drug safety issues. FDA should be given more scope of authority in the event of fatal drug reactions. Establish guidelines to reduce the impact of Pharmaceutical Companies influence on the FDA and establish a mandatory reporting system that mandates the Senators, Congressman, and Physicians to disclose any compensation or gifts provided to them from Pharmaceutical Companies as an incentive to offer their products●
Section X
●Establish Methadone Detoxification Programs in lieu of MMT. Offer alternatives and other therapies●
Section XI
●Limit the use of Government subsidized payments for services such as MMT, i.e. Medicaid. Use a workable timeline to detoxify and then sever payment from any subsidy for any further treatment for any noncompliant patient or after an extensive timeline has expired. Payments should only be made to work the patient through detoxification and not to maintain the patient on any medication for an extended period... ●
Section XII
●Establish Limited Use Only Guidelines for Use of methadone in the practice of pain management. Methadone should be the Drug of last resort with careful monitoring of the patient and blood plasma levels would be required, often, this would also assure a constant steady rate blood level and show methadone wasn’t being diverted. Limited number of medication should also be instituted and medication given in smaller increments pending outcomes of drug test and plasma concentrations when using Methadone for pain control.●
Section Xlll Outlaw all sales of Schedule II narcotics on the Internet. All content of this petition is protected by copyright laws and is the sole property of MAMA.Org Term "Right to Know, Full Disclosure".was created and is used by MAMA.Org. 12-2007 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ MRPIS - 10007 Update 12/2007
As of this date, we have now received approximately 40% of our goal for autopsy reports that we are seeking. Thank you to each and everyone of you who have sent in a report. We know that these reports are not just a piece of paper and we do not see them that way. Each report represents a wonderful life that has been lost and cut short from a drug and its toxic effects. We have also experienced loss from methadone, so we share in your grief. Thank you for your support as we all move forward together in this cause.
Robert Joseph Sutton
Forensic Friends Network
Robby L. Garvin "beatae memoriae"
'requiescit in pace'
'Dominus tecum'
________________________________________________________________________________ Our Autopsy Research Project: MRPIS-10007
Methadone Retrospective Postmortem Investigational Study
Objective: To identify the potential risk of life threatening toxic effects of methadone that often lead to a fatal outcome and to reduce the number of methadone associated fatalities by identifying these risk and making them well known to the public. This is a retrospective study on postmortem autopsy reports given by the next of kin in these deaths. This study is limited to postmortem autopsy reports, toxicology reports and death investigation reports in some instances. No ante mortem data of each individual’s medical history will be used for the purpose of this study, however: a parallel study on the effects of methadone using ante mortem data is more than plausible when the information becomes available to the study group. The time period for this study will be approximately 12 months in duration commencing on July 2007. All autopsy reports submitted are confidential and all personal identifying information will be immediately redacted from the report and a case number assigned to each report. Non-identifying personal information such as age, location, sex, etc., may be used later for statistical research or purposes not defined in this study. This study will represent only adult male and females, children are not defined for the purpose of this study. A summary of the study progress will be given periodically when information becomes available. Autopsy reports will be collected until the maximum of 150 are received or the deadline of March 2008 has been reached, the deadline may be amended should the need arise. For the purpose of this study short-term use and long-term effects of use are not defined, but the total effects of methadone are considered. Legal and use by diversion are not differentiated. The study may be amended in portion or entirety at the discretion of the program administrator and director.
Summary:
Investigative study limited to the postmortem autopsy reports, as defined above. The study will investigate the life threatening risk potential for Methadone HCL and potential for fatal toxicity. This study includes all body systems that are potentially affected by the toxic effects, these effects which most often lead to fatal outcome. Emphasis will be placed on Pulmotoxic and Cardiotoxic effects of methadone. We hope to show a forensic timeline of vital events that often lead up to system failure, from Methadone’s Fatal Footprint.
Joey New updates will be added as we progress with this study. Vital information will not be released until our final project is complete. We reserve the right to withold such theory and findings to protect the integrity of our work. NG ©2008 COPYRIGHT OF MOTHERS AGAINST MEDICAL ABUSE. All rights reserved. Use by written permission only.
|
|